These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 18234374)
21. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence. Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023 [TBL] [Abstract][Full Text] [Related]
22. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659 [TBL] [Abstract][Full Text] [Related]
23. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling. Zohar P; Kovacic M; Brezocnik M; Podbregar M Europace; 2005 Sep; 7(5):500-7. PubMed ID: 16087117 [TBL] [Abstract][Full Text] [Related]
24. The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction. Freestone B; Chong AY; Blann AD; Lip GY Thromb Res; 2006; 118(4):479-85. PubMed ID: 16318868 [TBL] [Abstract][Full Text] [Related]
25. Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation. Boodhoo LE; Mitchell AR; O'Connor J; Sulke N Int J Cardiol; 2005 Aug; 103(1):67-72. PubMed ID: 16061126 [TBL] [Abstract][Full Text] [Related]
26. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. Conway DS; Buggins P; Hughes E; Lip GY J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416 [TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070 [TBL] [Abstract][Full Text] [Related]
28. Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. Watson T; Shantsila E; Blann A; Lip GY Thromb Haemost; 2010 Aug; 104(2):327-34. PubMed ID: 20508899 [TBL] [Abstract][Full Text] [Related]
29. Differential recovery of regional atrial contraction after restoration of sinus rhythm after intraoperative linear radiofrequency ablation for atrial fibrillation. Boyd AC; Schiller NB; Ross DL; Thomas L Am J Cardiol; 2009 Feb; 103(4):528-34. PubMed ID: 19195515 [TBL] [Abstract][Full Text] [Related]
30. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis. Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117 [TBL] [Abstract][Full Text] [Related]
31. Activation of generalised inflammatory reaction following electrical cardioversion. Gajek J; Zyśko D; Mysiak A; Mazurek W Kardiol Pol; 2004 Sep; 61(9):225-31. PubMed ID: 15531934 [TBL] [Abstract][Full Text] [Related]
32. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956 [TBL] [Abstract][Full Text] [Related]
33. Time course for recovery of atrial mechanical and endocrine function post DC cardioversion for persistent atrial fibrillation. Thomas MD; Kalra PR; Jones A; Struthers AD; More RS Int J Cardiol; 2005 Jul; 102(3):487-91. PubMed ID: 16004895 [TBL] [Abstract][Full Text] [Related]
34. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation. Holmqvist F; Stridh M; Waktare JE; Sörnmo L; Olsson SB; Meurling CJ Eur Heart J; 2006 Sep; 27(18):2201-7. PubMed ID: 16956916 [TBL] [Abstract][Full Text] [Related]
35. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Smith P; Arnesen H Am J Cardiol; 2007 Jun; 99(11):1544-8. PubMed ID: 17531578 [TBL] [Abstract][Full Text] [Related]
36. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation]. Zyśko D; Gajek J; Mazurek W Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137 [TBL] [Abstract][Full Text] [Related]
37. Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. Soran H; Younis N; Currie P; Silas J; Jones IR; Gill G QJM; 2008 Mar; 101(3):181-7. PubMed ID: 18202088 [TBL] [Abstract][Full Text] [Related]
38. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Conway DS; Buggins P; Hughes E; Lip GY Am J Cardiol; 2004 Aug; 94(4):508-10. PubMed ID: 15325942 [TBL] [Abstract][Full Text] [Related]
39. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Ozaydin M; Varol E; Aslan SM; Kucuktepe Z; Dogan A; Ozturk M; Altinbas A Am J Cardiol; 2006 May; 97(10):1490-3. PubMed ID: 16679090 [TBL] [Abstract][Full Text] [Related]
40. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Letsas KP; Weber R; Bürkle G; Mihas CC; Minners J; Kalusche D; Arentz T Europace; 2009 Feb; 11(2):158-63. PubMed ID: 19010799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]